{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T10:07:17Z","timestamp":1781604437332,"version":"3.54.5"},"reference-count":74,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,6,5]],"date-time":"2014-06-05T00:00:00Z","timestamp":1401926400000},"content-version":"vor","delay-in-days":2773,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejves.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Vascular and Endovascular Surgery"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1016\/j.ejvs.2006.03.007","type":"journal-article","created":{"date-parts":[[2006,4,27]],"date-time":"2006-04-27T11:37:09Z","timestamp":1146137829000},"page":"478-483","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Managing Risk Factors for Atherosclerosis in Critical Limb Ischaemia"],"prefix":"10.1016","volume":"32","author":[{"given":"A.","family":"Gotts\u00e4ter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejvs.2006.03.007_bib1","first-page":"S1","article-title":"Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Concensus (TASC)","volume":"31","author":"Dormandy","year":"2000","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.ejvs.2006.03.007_bib2","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0950-821X(88)80002-1","article-title":"Epidemiology of atherosclerotic arterial disease in the lower limbs","volume":"2","author":"Fowkes","year":"1988","journal-title":"Eur J Vasc Surg"},{"key":"10.1016\/j.ejvs.2006.03.007_bib3","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/0002-9149(92)90046-2","article-title":"Amounts of coronary arterial narrowing by atherosclerotic plaque at necropsy in patients with lower extremity amputation","volume":"70","author":"Mautner","year":"1992","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ejvs.2006.03.007_bib4","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/0002-9149(94)90493-6","article-title":"Prevalence of coexistence of coronary artery disease, peripheral arterial disease, and atherothrombotic brain infarction in men and women > or = 62 years of age","volume":"74","author":"Aronow","year":"1994","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ejvs.2006.03.007_bib5","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1111\/j.1532-5415.1999.tb05208.x","article-title":"Prevalence of coexistence of coronary artery disease, ischemic stroke, and peripheral arterial disease in older persons, mean age 80 years, in an academic hospital-based geriatrics practice","volume":"47","author":"Ness","year":"1999","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.ejvs.2006.03.007_bib6","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0002-9149(01)01990-7","article-title":"Association of valvular aortic stenosis with symptomatic peripheral arterial disease in older persons","volume":"88","author":"Aronow","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ejvs.2006.03.007_bib7","first-page":"492","article-title":"Fatal myocardial infarction following lower extremity revascularization. Two hundred seventy-three patients followed six to eleven postoperative years","volume":"193","author":"Hertzer","year":"1981","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejvs.2006.03.007_bib8","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1053\/ejvs.2002.1747","article-title":"Ankle-brachial index and mortality in a cohort of questionnaire recorded leg pain on walking","volume":"24","author":"Jonsson","year":"2002","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2006.03.007_bib9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ehj.2003.10.033","article-title":"Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease","volume":"25","author":"Ostergren","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejvs.2006.03.007_bib10","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1056\/NEJM199202063260605","article-title":"Mortality over a period of 10 years in patients with peripheral arterial disease","volume":"326","author":"Criqui","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejvs.2006.03.007_bib11","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/jama.1993.03510040069031","article-title":"Decreased ankle\/arm blood pressure index and mortality in elderly women","volume":"270","author":"Vogt","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.ejvs.2006.03.007_bib12","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/ije\/25.6.1172","article-title":"Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population","volume":"25","author":"Leng","year":"1996","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.ejvs.2006.03.007_bib13","first-page":"321","article-title":"Defining the outcome of critical ischaemia: a one year prospective study","volume":"73","author":"Wolfe","year":"1986","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejvs.2006.03.007_bib14","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1078-5884(97)80203-1","article-title":"The study group of criticial chronic ischemia of the lower exremities. Long-term mortality and its predictors in patients with critical leg ischaemia","volume":"14","author":"The I.C.A.I. Group (Gruppo di Studio dell'Ischemia Cronica Critica degli Arti Inferiori)","year":"1997","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2006.03.007_bib15","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jvs.2005.03.025","article-title":"Inflammatory mediators are associated with 1-year mortality in critical limb ischemia","volume":"42","author":"Barani","year":"2005","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.ejvs.2006.03.007_bib16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.0954-6820.1986.tb02768.x","article-title":"Peripheral arterial disease\u2013natural outcome","volume":"220","author":"Lassila","year":"1986","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.ejvs.2006.03.007_bib17","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1177\/152660280200900403","article-title":"Balloon angioplasty in chronic critical limb ischemia: factors affecting clinical and angiographic outcome","volume":"9","author":"Balmer","year":"2002","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.ejvs.2006.03.007_bib18","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00000542-199001000-00025","article-title":"Perioperative cardiac morbidity","volume":"72","author":"Mangano","year":"1990","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejvs.2006.03.007_bib19","doi-asserted-by":"crossref","first-page":"894","DOI":"10.2337\/diacare.25.5.894","article-title":"UKPDS 59: hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes","volume":"25","author":"Adler","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejvs.2006.03.007_bib20","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00043798-199412000-00009","article-title":"Risk factors for atherosclerotic cardiovascular outcomes in different arterial territories","volume":"1","author":"Kannel","year":"1994","journal-title":"J Cardiovasc Risk"},{"key":"10.1016\/j.ejvs.2006.03.007_bib21","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/(SICI)1096-9136(199608)13:8<726::AID-DIA145>3.0.CO;2-P","article-title":"The management and outcome of critical limb ischaemia in diabetic patients: results of a national survey. Audit committee of the vascular surgical society of Great\u00a0Britain and Ireland","volume":"13","author":"da Silva","year":"1996","journal-title":"Diabet Med"},{"key":"10.1016\/j.ejvs.2006.03.007_bib22","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/0021-9681(79)90059-6","article-title":"The Basle longitudinal study: report on the relation of initial glucose level to baseline ECG abnormalities, peripheral artery disease, and subsequent mortality","volume":"32","author":"da Silva","year":"1979","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.ejvs.2006.03.007_bib23","first-page":"86","article-title":"Endovascular surgery for chronic limb ischaemia. Factors predicting immediate outcome on the basis of a nationwide vascular registry","volume":"90","author":"Vainio","year":"2001","journal-title":"Ann Chir Gynaecol"},{"key":"10.1016\/j.ejvs.2006.03.007_bib24","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jvs.2004.07.040","article-title":"Diabetes as an independent risk factor for early postoperative complications in critical limb ischemia","volume":"40","author":"Virkkunen","year":"2004","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.ejvs.2006.03.007_bib25","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1046\/j.1445-2197.2004.02915.x","article-title":"Diabetes and the outcome of infrainguinal bypass for critical limb ischaemia","volume":"74","author":"AhChong","year":"2004","journal-title":"ANZ J Surg"},{"key":"10.1016\/j.ejvs.2006.03.007_bib26","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/S0002-9149(99)80683-3","article-title":"Effect of intensive diabetes management on macrovascular events and risk factors in the diabetes control and complications trial","volume":"75","author":"The Diabetes Control and Complications Trial (DCCT) Research Group","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ejvs.2006.03.007_bib27","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.ejvs.2006.03.007_bib28","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0140-6736(05)67528-9","article-title":"On behalf of the PROactive investigators. Secondary prevention of macrovascular events in\u00a0patients with type 2 diabetes in the PROactive study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial","volume":"366","author":"Dormandy","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ejvs.2006.03.007_bib29","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/S0195-668X(03)00347-6","article-title":"European guidelines on cardiovascular disease prevention in clinical practice. Third joint task force of European and other societies on cardiovascular disease prevention in clinical practice","volume":"24","author":"De Backer","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejvs.2006.03.007_bib30","doi-asserted-by":"crossref","first-page":"69C","DOI":"10.1016\/S0002-9149(99)80474-3","article-title":"Range of serum cholesterol values in the population\u00a0developing coronary artery disease","volume":"76","author":"Kannel","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ejvs.2006.03.007_bib31","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S1078-5884(96)80170-5","article-title":"The\u00a0influence of smoking cessation and hypertriglyceridaemia on the progression of peripheral arterial disease and the onset of critical ischaemia","volume":"11","author":"Smith","year":"1996","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2006.03.007_bib32","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1053\/ejvs.2001.1431","article-title":"Lipoprotein (a) level and mortality in patients with critical lower limb ischaemia","volume":"22","author":"Cheng","year":"2001","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2006.03.007_bib33","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1067\/mva.2002.128301","article-title":"Serum lipids act as inverse acute phase reactants and are falsely low in patients with critical limb ischemia","volume":"36","author":"Bismuth","year":"2002","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.ejvs.2006.03.007_bib34","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0021-9150(98)00049-5","article-title":"Myocardial infarction and percent arteriographic stenosis of culprit lesion: report from the Program on the Surgical Control of the Hyperlipidemias (POSCH)","volume":"138","author":"Buchwald","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejvs.2006.03.007_bib35","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1161\/hq1101.098486","article-title":"Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors","volume":"21","author":"Takemoto","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ejvs.2006.03.007_bib36","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4 S)","volume":"344","author":"Scandinavian Simvastatin Survival Study Group","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.ejvs.2006.03.007_bib37","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1161\/01.CIR.92.7.1758","article-title":"Kuopio Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries","volume":"92","author":"Salonen","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2006.03.007_bib38","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial","volume":"360","author":"Heart Protection Study Collaborative Group","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ejvs.2006.03.007_bib39","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.ehj.2004.02.012","article-title":"Statin therapy improves cardiovascular outcome of patients with peripheral artery disease","volume":"25","author":"Schillinger","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejvs.2006.03.007_bib40","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1161\/01.CIR.0000050380.64025.07","article-title":"Statin use and leg functioning in patients with and without lower-extremity peripheral arterial disease","volume":"107","author":"McDermott","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2006.03.007_bib41","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1161\/01.CIR.0000090686.57897.F5","article-title":"Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease","volume":"108","author":"Mohler","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2006.03.007_bib42","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jvs.2003.08.030","article-title":"Patients undergoing infrainguinal bypass to treat atherosclerotic vascular disease are underprescribed cardioprotective medications: effect on graft patency, limb salvage, and mortality","volume":"39","author":"Henke","year":"2004","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.ejvs.2006.03.007_bib43","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jacc.2004.10.048","article-title":"Statins decrease perioperative cardiac complications in patients undergoing noncardiac vascular surgery: the Statins for Risk Reduction in Surgery (StaRRS) study","volume":"45","author":"O'Neil-Callahan","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejvs.2006.03.007_bib44","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jama.286.11.1317","article-title":"Peripheral arterial disease detection, awareness, and treatment in primary care","volume":"286","author":"Hirsch","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ejvs.2006.03.007_bib45","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1001\/archinte.160.19.2934","article-title":"Determinants of peripheral arterial disease in the elderly: the Rotterdam study","volume":"160","author":"Meijer","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ejvs.2006.03.007_bib46","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0021-9150(03)00204-1","article-title":"High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study","volume":"172","author":"Diehm","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejvs.2006.03.007_bib47","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","article-title":"Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group","volume":"351","author":"Hansson","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.ejvs.2006.03.007_bib48","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The heart outcomes prevention evaluation study investigators","volume":"342","author":"Yusuf","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejvs.2006.03.007_bib49","first-page":"2413","article-title":"The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure","volume":"157","year":"1997","journal-title":"Arch\u00a0Intern Med"},{"key":"10.1016\/j.ejvs.2006.03.007_bib50","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1001\/archinte.164.4.440","article-title":"Relationship between intermittent claudication, inflammation, thrombosis, and recurrent cardiac events among survivors of myocardial infarction","volume":"164","author":"Narins","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ejvs.2006.03.007_bib51","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1001\/archinte.1991.00400090063012","article-title":"Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease. a meta-analysis of randomized controlled trials","volume":"151","author":"Radack","year":"1991","journal-title":"Arch Intern Med"},{"issue":"Suppl. C","key":"10.1016\/j.ejvs.2006.03.007_bib52","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/eurheartj\/15.suppl_C.2","article-title":"Peripheral vascular effects of beta-blockers","volume":"15","author":"Heintzen","year":"1994","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejvs.2006.03.007_bib53","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.308.6921.81","article-title":"Collaborative overview of randomised trials of antiplatelet therapy\u2013I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients","volume":"308","year":"1994","journal-title":"BMJ"},{"key":"10.1016\/j.ejvs.2006.03.007_bib54","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.ejvs.2006.03.007_bib55","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/bmj.308.6922.159","article-title":"Collaborative overview of randomised trials of antiplatelet therapy\u2013II: Maintenance of vascular graft or arterial patency by antiplatelet therapy","volume":"308","year":"1994","journal-title":"BMJ"},{"key":"10.1016\/j.ejvs.2006.03.007_bib56","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)","volume":"348","author":"CAPRIE Steering Committee","year":"1996","journal-title":"Lancet"},{"issue":"Suppl. 3","key":"10.1016\/j.ejvs.2006.03.007_bib57","doi-asserted-by":"crossref","first-page":"609S","DOI":"10.1378\/chest.126.3_suppl.609S","article-title":"Antithrombotic therapy in peripheral arterial occlusive disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy","volume":"126","author":"Clagett","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.ejvs.2006.03.007_bib58","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1001\/jama.292.15.1867","article-title":"Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease","volume":"292","author":"Tran","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ejvs.2006.03.007_bib59","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"The clopidogrel in unstable angina to prevent recurrent events trial investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejvs.2006.03.007_bib60","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0140-6736(04)16721-4","article-title":"Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial","volume":"364","author":"Diener","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ejvs.2006.03.007_bib61","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.jvs.2004.08.049","article-title":"Influence of smoking on incidence and prevalence of peripheral arterial disease","volume":"40","author":"Willigendael","year":"2004","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.ejvs.2006.03.007_bib62","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.0954-6820.1985.tb08820.x","article-title":"Factors of prognostic importance for subsequent rest pain in patients with intermittent claudication","volume":"218","author":"Jonason","year":"1985","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.ejvs.2006.03.007_bib63","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1177\/1358863X9700200314","article-title":"The role of tobacco cessation, antiplatelet and lipid-lowering therapies in the treatment of peripheral arterial disease","volume":"2","author":"Hirsch","year":"1997","journal-title":"Vasc Med"},{"key":"10.1016\/j.ejvs.2006.03.007_bib64","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/BF03187503","article-title":"The effects of postoperative smoking on femoropopliteal bypass grafts","volume":"3","author":"Ameli","year":"1989","journal-title":"Ann Vasc Surg"},{"issue":"Suppl.","key":"10.1016\/j.ejvs.2006.03.007_bib65","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1002\/bjs.1800691309","article-title":"The measured effect of stopping smoking on intermittent claudication","volume":"69","author":"Quick","year":"1982","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejvs.2006.03.007_bib66","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.0954-6820.1987.tb00891.x","article-title":"Cessation of smoking in patients with intermittent claudication. Effects on the risk of peripheral vascular complications, myocardial infarction and mortality","volume":"221","author":"Jonason","year":"1987","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.ejvs.2006.03.007_bib67","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1056\/NEJM199001253220401","article-title":"Decline in the risk of myocardial infarction among women who stop smoking","volume":"322","author":"Rosenberg","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejvs.2006.03.007_bib68","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/0895-4356(94)90128-7","article-title":"A marked decline in the prevalence and incidence of intermittent claudication in Icelandic men 1968\u20131986: a strong relationship to smoking and serum cholesterol\u2013the Reykjavik Study","volume":"47","author":"Ingolfsson","year":"1994","journal-title":"J Clin Epidemiol"},{"issue":"Issue 3","key":"10.1016\/j.ejvs.2006.03.007_bib69","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000146.pub2","article-title":"Nicotine replacement therapy for smoking cessation","author":"Silagy","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejvs.2006.03.007_bib70","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1378\/chest.119.5.1357","article-title":"Bupropion for smoking cessation: predictors of successful outcome","volume":"119","author":"Dale","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.ejvs.2006.03.007_bib71","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1161\/01.CIR.0000035649.39669.CE","article-title":"Missed opportunities to treat atherosclerosis in patients undergoing peripheral vascular interventions: insights from the University of Michigan Peripheral Vascular Disease Quality Improvement Initiative (PVD-QI2)","volume":"106","author":"Mukherjee","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2006.03.007_bib72","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/gerona\/60.2.255","article-title":"Prevalence of symptomatic peripheral arterial disease, modifiable risk factors, and appropriate use of drugs in the treatment of peripheral arterial disease in older persons seen in a university general medicine clinic","volume":"60","author":"Ness","year":"2005","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.ejvs.2006.03.007_bib73","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1053\/ejvs.2000.1293","article-title":"The lack of cardiovascular risk factor management in patients with critical limb ischaemia","volume":"21","author":"Bismuth","year":"2001","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2006.03.007_bib74","first-page":"59","article-title":"Suboptimal treatment of risk factor for athero-sclerosis in critical limb ischemia","volume":"24","author":"Barani","year":"2005","journal-title":"Int Angiol"}],"container-title":["European Journal of Vascular and Endovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078588406001602?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078588406001602?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:40:48Z","timestamp":1761043248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078588406001602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":74,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S1078588406001602"],"URL":"https:\/\/doi.org\/10.1016\/j.ejvs.2006.03.007","relation":{},"ISSN":["1078-5884"],"issn-type":[{"value":"1078-5884","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Managing Risk Factors for Atherosclerosis in Critical Limb Ischaemia","name":"articletitle","label":"Article Title"},{"value":"European Journal of Vascular and Endovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejvs.2006.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}